How To Spot a 100% Winner
It wasn’t long ago that I highlighted Planet Labs as a stock with the potential to blast off. At the time it was sitting at $1.90 per share.
Fast forward to the present and Planet Labs has soared well above $4 per share and is now posting gains of over 100%.
So what was it that revealed the hallmarks of a stock about to pop? » Read more about: How To Spot a 100% Winner »
Read More
2 Stocks For The Next Bull Market
With retirement portfolios losing almost $1 in every $4 invested this year, investor sentiment is clearly bearish. Losing almost a quarter of your invested portfolio is bad, but that’s assuming you had it invested in the S&P 500.
For those who speculated on high growth names like Affirm, Upstart, and SoFi, the bear market has acted like a grim reaper to their holdings.
» Read more about: 2 Stocks For The Next Bull Market »
Read More
Buffett Stock Set For Monster Comeback?
It’s been a brutal year for RH, better known to most as Restoration Hardware, a stock Buffett holds in his Berkshire Hathaway portfolio. The bear market has wiped out more than half of its value this year. At last count, it was down 53%.
Even the best stocks get taken out to the woodshed and chopped in a bear market.
» Read more about: Buffett Stock Set For Monster Comeback? »
Read More
1 Billion Reasons To Buy This Industry Leader
The day after releasing its fiscal 2023 second-quarter earnings report, DocuSign (DOCU) stock rose over 10%. Investors liked what they saw as the cloud-based e-signature leader beat Wall Street’s expectations, but there are still some major red flags.
Is now the time to buy into this leading e-signature company?
» Read more about: 1 Billion Reasons To Buy This Industry Leader »
Read More
1 Organ Transplant Disruptor to Buy on the Dip
TransMedics (NASDAQ:TMDX) is an innovative biotechnology company that may well have the potential to disrupt the $11 billion organ transplant industry.
The company’s unique organ care system technology protects and monitors donor organs before they are transplanted into patients, resulting in improved organ health and outcomes. TransMedics also provides logistical services,
» Read more about: 1 Organ Transplant Disruptor to Buy on the Dip »
Read MoreThe Ivy
Uber’s Stock Is Down But Business Is Booming, Why It Might Be a Buy
Uber (NYSE: UBER) has had its fair share of ups and downs lately. After peaking last October, the stock took a hit on the heels of Tesla’s flashy Cybercab announcement, a move that spooked investors and led to a sustained selloff into year-end.
While the stock has been slowly clawing its way back,
» Read more about: Uber’s Stock Is Down But Business Is Booming, Why It Might Be a Buy »
Read MoreThe Spotlight
Palantir Soared 20.5% But Is It Just The Start?
Palantir Technologies (PLTR) has been in business for 20 years but it’s only recently that it’s accomplished one of its most impressive feats to-date, tripling the number of users of its artificial intelligence platform in a single quarter.
That spike in demand translated to a spectacular Q3 that blew away Wall Street’s expectations.
» Read more about: Palantir Soared 20.5% But Is It Just The Start? »
Read MoreThe Daily
Unpacking the Latest Options Trading Trends in BioNTech
Today, Benzinga’s options scanner spotted 20 options trades for BioNTech. This is not a typical pattern. The sentiment among these major traders is split, with 55% bullish and 20% bearish. Among all …
» Read more about: Unpacking the Latest Options Trading Trends in BioNTech »